Diligence memo · auto-generated · as of July 3, 2026

All Inspire Health, Inc.

All Inspire Health, Inc. looks over-valued against its niche peers and is active on financing cadence.

SourceRaising on rhythm with a 2.4× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

All Inspire Health, Inc. operates in Healthtech, based in CUMBERLAND GATE, BROOKLYN.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

All Inspire Health, Inc. has raised $137M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $85M on 2025-06-25.

Most recent recorded round closed around 2025-06-25.

Valuation (modeled)modeled

Provath models All Inspire Health, Inc. at approximately $550M (range $309M–$730M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.66× the median modeled value of Series C Healthtech companies in 2025–2027 (19 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 15 months.

Last raise 12 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 2.4× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 97% of Healthtech peers (2138 compared).

Modeled value ranks above 94% of those peers.

Closest niche peers: Thyme Care, Inc., Cohere Health Inc., Harbor Health Team Inc., Apreo Health, Inc., 4C Medical Technologies, Inc..

Peoplefiled

11 named people on file across officers, directors and signatories.

Risks & flagsmixed

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.